- Q3 comparable sales +7%
- Q3 adjusted EPS $1.42 vs estimate $1.42
- Q3 net sales $13.01B vs estimate $13B
Abbott reported Q3 comparable sales growth of 7%, in line with the earlier earnings release. The metric reflects organic demand across the company's medical device, diagnostics, and nutrition segments.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.